Nutra Pharma Corp
Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases in the United States. The company offers Nyloxin, an over-the-counter (OTC) pain reliever; Nyloxin Extra Strength, a non-narcotic and non-addictive treatment fo… Read more
Nutra Pharma Corp (NPHC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: -0.001x
Based on the latest financial reports, Nutra Pharma Corp (NPHC) has a cash flow conversion efficiency ratio of -0.001x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($19.07K) by net assets ($-14.82 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nutra Pharma Corp - Cash Flow Conversion Efficiency Trend (2001–2025)
This chart illustrates how Nutra Pharma Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nutra Pharma Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nutra Pharma Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Compagnie Industrielle et Financière d'Entreprises SA
PA:INFE
|
0.143x |
|
Haffner Energy SA
PA:ALHAF
|
-0.330x |
|
ASM Automation Group Berhad
KLSE:0362
|
0.010x |
|
Gujarat Raffia Industries Limited
NSE:GUJRAFFIA
|
0.123x |
|
CPL Group Public Company Limited
BK:CPL
|
0.066x |
|
INCREDIBLE INDUSTRIES LIMITED
NSE:INCREDIBLE
|
0.019x |
|
Johan Holdings Bhd
KLSE:3441
|
-0.013x |
|
NorthView Acquisition Corporation Warrant
PINK:NVACW
|
0.007x |
Annual Cash Flow Conversion Efficiency for Nutra Pharma Corp (2001–2025)
The table below shows the annual cash flow conversion efficiency of Nutra Pharma Corp from 2001 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-12.38 Million | $-762.43K | 0.062x | +54.19% |
| 2023-12-31 | $-13.77 Million | $-550.04K | 0.040x | -35.15% |
| 2022-12-31 | $-12.38 Million | $-762.43K | 0.062x | -26.28% |
| 2021-12-31 | $-20.88 Million | $-1.74 Million | 0.084x | -33.30% |
| 2020-12-31 | $-5.94 Million | $-743.66K | 0.125x | +97.10% |
| 2019-12-31 | $-11.70 Million | $-743.66K | 0.064x | -62.27% |
| 2018-12-31 | $-5.94 Million | $-999.95K | 0.168x | -19.95% |
| 2017-12-31 | $-5.41 Million | $-1.14 Million | 0.210x | -30.56% |
| 2016-12-31 | $-4.48 Million | $-1.36 Million | 0.303x | +6.37% |
| 2015-12-31 | $-3.57 Million | $-1.02 Million | 0.285x | +591.28% |
| 2014-12-31 | $-3.59 Million | $-148.13K | 0.041x | -67.26% |
| 2013-12-31 | $-4.22 Million | $-531.04K | 0.126x | -37.59% |
| 2012-12-31 | $-3.58 Million | $-721.24K | 0.202x | -62.48% |
| 2010-12-31 | $-2.53 Million | $-1.36 Million | 0.537x | -68.55% |
| 2009-12-31 | $-1.14 Million | $-1.96 Million | 1.709x | +347.63% |
| 2008-12-31 | $-2.56 Million | $-976.09K | 0.382x | -7.42% |
| 2007-12-31 | $-1.95 Million | $-805.37K | 0.412x | -55.77% |
| 2006-12-31 | $-1.86 Million | $-1.74 Million | 0.932x | -59.82% |
| 2005-12-31 | $-659.13K | $-1.53 Million | 2.320x | +107.20% |
| 2004-12-31 | $46.90K | $-1.51 Million | -32.243x | -142484.12% |
| 2003-12-31 | $3.49 Million | $-78.87K | -0.023x | -17091.50% |
| 2002-12-31 | $-45.08K | $-6.00 | 0.000x | -99.96% |
| 2001-12-31 | $-134.35K | $-49.99K | 0.372x | -- |